Olson, R., Jiang, W., Liu, M., Bergman, A., Schellenberg, D., Mou, B., Alexander, A., Carolan, H., Hsu, F., Miller, S., Atrchian, S., Chan, E., Ho, C., Mohamed, I., Lin, A., Berrang, T., Bang, A., Chng, N., Matthews, Q., Mestrovic, A., Hyde, D., Huang, V., Lund, C., Pai, H., Valev, B., Lefresne, S., & Tyldesley, S. (n.d.). 2: Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR) for Up to Five Oligometastases: Preliminary Results of the SABR-5 Trial. Radiotherapy and oncology, 163, S4–. http://access.bl.uk/ark:/81055/vdc_100145646777.0x000040